L-Theanine Side Effects

Reported L-Theanine side effects

L-theanine has one of the cleanest safety profiles of any CNS-active nootropic, with no dependence, withdrawal, tolerance, or serious adverse events reported in controlled trials at doses up to 900mg/day for weeks to months. Common mild side effects (all reported at rates similar to placebo in RCTs): Mild headache, particularly at higher doses (>400mg) in first-time users Transient GI upset (nausea, loose stools) at higher doses Light-headedness or dizziness, particularly if taken without food Dry mouth at higher doses Mild drowsiness in a minority of users (particularly at evening doses above 200mg) What theanine does NOT cause. No dependence. No withdrawal syndrome on discontinuation. No tolerance after years of daily use. No respiratory depression even at high doses. No cognitive impairment (the opposite — modest cognitive enhancement when paired with caffeine). No sexual dysfunction (unlike SSRIs). No metabolic effects (unlike many psychotropics). No extrapyramidal symptoms. No QT prolongation or other cardiac concerns at normal supplement doses. Blood pressure. Modest reduction (2-5 mmHg systolic) at 200-400mg doses has been reported in multiple studies. This is clinically trivial in normotensive adults but could produce additive hypotension in individuals on antihypertensive medications — monitor BP on initiation if you are on any BP-lowering drug. Stimulant interactions (theoretical vs practical). Theanine is commonly and safely co-used with caffeine, methylphenidate, amphetamine (for ADHD), and other stimulants. The empirical interaction is generally favourable — theanine reduces stimulant-associated jitter without blunting the therapeutic effect. No pharmacokinetic interaction has been documented. SSRIs, SNRIs, antidepressants. No documented clinically significant interaction. Commonly co-used without reported problems. Benzodiazepines, Z-drugs. Theoretically additive for sedation/anxiolysis; if you are taking a prescribed benzodiazepine, you do not need theanine on top and the combination adds little. Anticoagulants. No documented clinically significant interaction; theanine does not meaningfully affect coagulation. Pregnancy. Limited safety data, though decades of dietary green tea exposure provides substantial real-world reassurance at low-to-moderate doses. Higher therapeutic doses (200mg+/day) during pregnancy should be discussed with a clinician. Pediatric use. Lyon 2011 specifically studied 200mg BID in boys aged 8-12 with ADHD-associated sleep problems and reported favourable safety. Pediatric use outside the ADHD-sleep indication should involve clinician input. High-dose considerations. Doses above 600mg in single administration occasionally produce more pronounced dizziness, sedation, or headache. No serious toxicity has been reported at any oral dose tested in human research. Quality control. The main safety concern for L-theanine supplements is product quality — powders labelled as "L-theanine" have occasionally been found contaminated or adulterated. Suntheanine® (the standardised enzymatic L-theanine) has the strongest third-party testing pedigree; generic L-theanine from reputable brands (NOW Foods, Jarrow, Thorne, Doctor's Best, Pure Encapsulations, Bulk Supplements) is typically well-quality-controlled. Avoid "proprietary blends" with unspecified theanine content. When to stop and consult a clinician. Any unusual reaction (severe headache, persistent nausea, unexpected mood change) should prompt discontinuation and, if symptoms persist, clinician evaluation. For generalised anxiety or mood concerns not responding to L-theanine, first-line treatments (SSRI, SNRI, CBT) are more effective.

When to continue, reduce, or stop L-Theanine

L-Theanine contraindications

Absolute contraindications: none L-theanine has one of the cleanest safety profiles in the nootropic category. No absolute contraindications have been established from controlled trials or post-marketing surveillance. Relative contraindications / use with caution: Hypotension or orthostatic intolerance. Theanine modestly lowers BP (2-5 mmHg systolic at 200-400mg). In individuals with orthostatic hypotension, POTS, or borderline-low baseline BP, start at 100mg and assess. Antihypertensive medication. Additive BP reduction possible. Monitor BP on initiation; unlikely to require dose adjustment to BP medications but worth awareness. Pregnancy. Limited safety data beyond dietary green tea exposure. Low-to-moderate doses likely safe; high therapeutic doses should be discussed with clinician. Breastfeeding. Theanine crosses into breast milk (dietary exposure is unavoidable in tea-drinking cultures). Effect on infant unclear; clinician input recommended for supplemental doses. Severe hepatic impairment. Theanine is partially hepatic-metabolised; conservative dosing (100mg) is reasonable. Concurrent strong sedative use. Benzodiazepines, Z-drugs, high-dose kava — theoretical additive effect. Clinically usually trivial but worth awareness. Pediatric use outside research-supported indications. Lyon 2011 supports 200mg BID for 8-12yo boys with ADHD-sleep issues; other pediatric applications should involve clinician input. Interactions (mostly benign): Caffeine. Favourable combination (standard of the nootropic field). Stimulant ADHD medications. Favourable combination; reduces jitter without blunting efficacy. SSRIs, SNRIs. No documented clinically significant interaction. Antipsychotics. Positive adjunctive data (Ritsner 2011); compatible. Anticoagulants. No interaction. Oral contraceptives. No interaction. Thyroid hormone. No interaction. Grapefruit juice. No interaction (not CYP3A4-metabolised). Practical bottom line. For most healthy adults, L-theanine is safe to add without clinician consultation. The clearest caution is additive BP reduction with antihypertensives. Pregnancy, breastfeeding, and significant hepatic disease warrant discussion with a clinician, but the baseline safety profile is exceptional.

Why vendor quality drives L-Theanine side-effect frequency

Research-compound communities consistently report that adverse-event frequency tracks with source quality. Three reasons: (1) impurity profiles vary by lab (residual synthesis byproducts can trigger reactions); (2) mislabeled mass means actual dose can be 50-150% of stated dose; (3) reconstitution-grade water and capping methodology affect long-term storage stability. COA-verified vendors with published HPLC data minimize all three failure modes. Check a vendor's COA record and Trust Score before you buy.

L-Theanine side effects FAQ

Research-use disclaimer. All safety information on this page summarizes published research literature and community-reported reactions. It is not medical advice and not authorization for human consumption. Always consult a licensed practitioner before any compound enters a clinical context. Compounds linked from this page are sold for research-use only.
Affiliate disclosure. See our affiliate disclosure .